Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in CashFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Deferred Taxes (2021)

Goldenwell Biotech filings provide 1 years of Deferred Taxes readings, the most recent being -$3690.0 for Q4 2021.

  • On a quarterly basis, Deferred Taxes changed N/A to -$3690.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $47779.0, a N/A change, with the full-year FY2021 number at $47779.0, changed N/A from a year prior.
  • Deferred Taxes hit -$3690.0 in Q4 2021 for Goldenwell Biotech, up from -$5572.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $62586.0 in Q1 2021 to a low of -$5572.0 in Q3 2021.